ARTICLE | Company News
PharmaGenics Inc., Xenova, Memorial Sloan Kettering Cancer Center other research news
October 2, 1995 7:00 AM UTC
The parties received a five-year Cooperative Agreement Award worth up to $2.3 million from the National Cancer Institute to discover drugs that modulate the function of the p53 tumor suppressor gene and related genes associated with a range of cancers. ...